Clindamycin is a semisynthetic antibiotic in the lincosamide class. It inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome, thereby preventing peptide chain elongation. This action is bacteriostatic or bactericidal, depending on the organism and drug concentration.